heart icon heart icon
Our Stories
Our Company
Follow Us
Explore more Johnson & Johnson sites:
Austrailia
Argentina
Brazil
Canada
Chile
China
Colombia
Costa Rica
Czech Republic
Ecuador
Germany
India
Japan
Mexico
New Zealand / Pacific
Paraguay
Peru
Philippines
Russia
Switzerland
German
English
French
Italian
Uruguay
United States
Venezuela
Share

Media Center

Read the Release
Johnson & Johnson's New Chief Financial Officer Answers 7 Popular Investor Questions
Johnson & Johnson's New Chief Financial Officer Answers 7 Popular Investor Questions
5 Important Facts About the Safety of Talc
4 Amazing Men and Women at the Forefront of HIV Work
Beyond the Ball: How the World Cup Helps Unite Us

Latest Press Releases

Innovation
July 20, 2018
Johnson & Johnson to Present New Data for Investigational Preventive Vaccine and Single-Tablet Treatment Regimens for HIV-1 at AIDS 2018
Innovation
July 17, 2018
Janssen Announces U.S. FDA Approval of SYMTUZA™ (D/C/F/TAF), the First and Only Complete Darunavir-Based Single-Tablet Regimen for the Treatment of HIV-1 Infection
Our Company
July 17, 2018
Johnson & Johnson Reports 2018 Second-Quarter Results:
Innovation
July 16, 2018
Phase 3 CREDENCE Renal Outcomes Trial of INVOKANA® (canagliflozin) is Being Stopped Early for Positive Efficacy Findings
July 16, 2018
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2018
Innovation
July 13, 2018
U.S. FDA Extends Review Timeline for INVOKANA® (canagliflozin) Supplemental New Drug Application
See All Press Releases

Photos, Videos, Infographics & More

J&J Fast Facts

Our Company
We Work All Over the World
We Work All Over the World
We have over 134,000 employees working across more than 260 operating companies located in 60 countries around the world.
Get to know Johnson & Johnson
See All Fast Facts

Social Media

  • RT @JNJGlobalHealth: Today at #TB2018, #JNJ is proud to announce our newest commitment in partnership with @HealthZA to encourage greater s…
    JNJNews
  • #JNJ co-founder James Wood Johnson took the principles of Johnson & Johnson so seriously, he signed his name to the… https://t.co/RwMF6ezGvE
    JNJNews
  • @bkgut3 Thanks for reaching out! This product was divested on January 26, 2013 to Valeant Pharmaceuticals. Have a great day!
    JNJNews
Follow Us On Twitter

More from Johnson & Johnson

This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.